Terms ending in 2026
Every in-force patent on Abbott Laboratories's record whose computed term ends in 2026, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,621,282 | Probe Washing Cups and Methods In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 10,578,602 | Disposable Chamber for Analyzing Biologic Fluids In force · Medium confidence | Abbott Laboratories | In force | Medium confidence | |
| US 7,504,520 | Antagonists of the Vanilloid Receptor Subtype 1 (VR1) and Use Thereof In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 7,763,731 | Anti-Viral Compounds In force · High confidence | AbbVie Inc. | In force | High confidence | |
| US 7,767,684 | Apoptosis Promoters In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | |
| US D673,040 | Portion of a Powder Cap for a Liquid Container In force · Medium confidence | Abbott Laboratories | In force | Medium confidence | |
| US 8,511,499 | Container In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 8,857,645 | Container In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 9,505,522 | Container In force · High confidence | Abbott Laboratories | In force | High confidence | |
| US 10,583,969 | Container In force · High confidence | Abbott Laboratories | In force | High confidence | |
| 2 more term ends in 2026 · Pro | |||||
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12, all of them expiring within the 18 months from Nov 17, 2026.
8 of these are in force and held by Abbott Laboratories.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.